Attached files
file | filename |
---|---|
EX-5.01 - EXHIBIT 5.01 - NxStage Medical, Inc. | c08781exv5w01.htm |
EX-1.01 - EXHIBIT 1.01 - NxStage Medical, Inc. | c08781exv1w01.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 17, 2010
NxSTAGE MEDICAL, INC.
(Exact name of registrant as specified in its charter)
Delaware | 000-51567 | 04-3454702 | ||
(State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
439 South Union Street, 5th Floor, Lawrence, MA |
01843 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrants telephone number, including area code: (978) 687-4700
(Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
(d) | Exhibits |
Exhibit | ||
Number | Description | |
1.01
|
Underwriting Agreement, dated as of November 17, 2010, between NxStage Medical, Inc. and Canaccord Genuity Inc. | |
5.01
|
Opinion of Hogan Lovells US LLP | |
23.01
|
Consent of Hogan Lovells US LLP (included in Exhibit 5.01) |
2
NXSTAGE MEDICAL, INC. |
||||
Date: November 23, 2010 | By: | /s/ Robert S. Brown | ||
Robert S. Brown | ||||
Chief Financial Officer and Senior Vice President | ||||
3
Exhibit | ||
Number | Description | |
1.01
|
Underwriting Agreement, dated as of November 17, 2010, between NxStage Medical, Inc. and Canaccord Genuity Inc. | |
5.01
|
Opinion of Hogan Lovells US LLP | |
23.01
|
Consent of Hogan Lovells US LLP (included in Exhibit 5.01) |
4